Antivirals against human polyomaviruses: Leaving no stone unturned.
Sign Up to like & getrecommendations! Published in 2021 at "Reviews in medical virology"
DOI: 10.1002/rmv.2220
Abstract: Human polyomaviruses (HPyVs) encompass more than 10 species infecting 30%-90% of the human population without significant illness. Proven HPyV diseases with documented histopathology affect primarily immunocompromised hosts with manifestations in brain, skin and renourinary tract… read more here.
Keywords: stone unturned; polyomaviruses leaving; leaving stone; polyomavirus associated ... See more keywords
Levels of donor‐derived cell‐free DNA and chemokines in BK polyomavirus‐associated nephropathy
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Transplantation"
DOI: 10.1111/ctr.14785
Abstract: BK polyomavirus‐associated nephropathy (BKPyVAN) carries a risk of irreversible allograft injury. While detection of BK viremia and biopsy assessment are the current diagnostic gold standard, the diagnostic value of biomarkers reflecting tissue injury (donor‐derived cell‐free… read more here.
Keywords: polyomavirus associated; derived cell; cell free; donor derived ... See more keywords
Granulomatous inflammation in BK polyomavirus–associated nephropathy
Sign Up to like & getrecommendations! Published in 2018 at "Transplant Infectious Disease"
DOI: 10.1111/tid.12939
Abstract: Evolving BK polyomavirus–associated nephropathy (BKPyVAN) is characterized by tubulointerstitial inflammation that closely resembles acute T‐cell–mediated allograft rejection if tubulitis is significant. The cellular composition of the inflammation varies during the course of BKPyVAN, and clusters… read more here.
Keywords: associated nephropathy; granulomatous inflammation; inflammation; polyomavirus associated ... See more keywords
Low‐dose cidofovir and conversion to mTOR‐based immunosuppression in polyomavirus‐associated nephropathy
Sign Up to like & getrecommendations! Published in 2019 at "Transplant Infectious Disease"
DOI: 10.1111/tid.13228
Abstract: Polyomavirus‐associated nephropathy (PVAN) remains a relevant complication following kidney transplantation with allograft loss rates of up to 50%. Reduction in overall immunosuppression is a cornerstone of therapy, whereas no specific antiviral regimen has shown conclusive… read more here.
Keywords: associated nephropathy; low dose; dose cidofovir; polyomavirus associated ... See more keywords
An application of the 2018 Banff Classification for BK polyomavirus‐associated nephropathy in renal transplantation
Sign Up to like & getrecommendations! Published in 2020 at "Transplant Infectious Disease"
DOI: 10.1111/tid.13557
Abstract: There is still a lack of a recognized morphological classification of BK viral nephropathy (BKVN) which can better reflect the clinical manifestations and prognosis. read more here.
Keywords: banff classification; 2018 banff; classification; application 2018 ... See more keywords
Clinical Relevance of Absolute BK Polyoma Viral Load Kinetics in Patients With Biopsy Proven BK Polyomavirus Associated Nephropathy
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2021.791087
Abstract: Introduction: The absolute BK viral load is an important diagnostic surrogate for BK polyomavirus associated nephropathy (PyVAN) after renal transplant (KTX) and serial assessment of BK viremia is recommended. However, there is no data indicating… read more here.
Keywords: viral load; polyomavirus associated; load; load kinetics ... See more keywords